 |
|
Researchers report breakthrough against world's deadliest viruses
June 06, 2005New Ebola, Marburg Vaccines effective in animal models
WINNIPEG, Manitoba and FREDERICK, Maryland - Scientists from the Public Health Agency of Canada-with assistance from the U.S. Army Medical Research Institute of Infectious Diseases-have developed vaccines against the Ebola and Marburg viruses that have been shown to be effective in non-human primates.
In a study published in this month's Nature Medicine, Canadian researchers Dr. Heinz Feldmann and Dr. Steven Jones of PHAC's National Microbiology Laboratory and Dr. Thomas Geisbert of USAMRIID report that the vaccines have proven 100 percent effective in protecting monkeys against infection from these often deadly viruses.
Monkeys are known to develop hemorrhagic fever symptoms that are similar to those observed in humans infected by these viruses. Demonstrating that these vaccines are safe and effective in monkeys is a promising indicator of their real potential for use in humans.
"When you see the tragedies these viruses cause, it's very frustrating that we can't do more to help people," said Dr. Feldmann, who (along with Dr. Jones and others from PHAC) has been providing on-site rapid diagnostic support to the current Marburg outbreak in Angola. "It'll be some time before we can use these vaccines in the field, but it's satisfying to know that we're getting closer."
According to Dr. Geisbert, this is the first vaccine system, or platform, that has protected nonhuman primates from both Ebola and Marburg. "In addition, the vaccine targets dendritic cells, which are the same cells that Ebola and Marburg attack," said Dr. Geisbert. "These cells are also important in generating a protective immune response. So the vaccine goes exactly where we want it to go."
The study describes how Canadian researchers developed the vaccines by replacing a surface protein in an animal pathogen, called vesicular stomatitis virus, with a surface protein from either the Ebola or Marburg viruses. Following extensive work, including trials with mice and guinea pigs, the PHAC researchers collaborated with USAMRIID to prove their efficacy in non-human primates.
Canadian Health Minister Ujjal Dosanjh and Dr. Carolyn Bennett, Minister of State (Public Health), praised the work of the scientists in developing the vaccine and providing support to the outbreak in Angola.
"This speaks volumes about the dedication and expertise of these individuals, and also what can be achieved through international collaboration," said Minister Dosanjh. Minister Bennett added that people everywhere could benefit from the vaccine development,"in stopping outbreaks where they originate as well as reducing the risk that these viruses will be used in bioterrorism."
Colonel Erik A. Henchal, commander of USAMRIID, said the study illustrates the benefits of collaborative research to develop medical countermeasures for biodefense.
"Relationships like this contribute to better science and ultimately better protection for military service members and civilians alike."
US Army Medical Research Institute of Infectious D
Monkeys are known to develop hemorrhagic fever symptoms that are similar to those observed in humans infected by these viruses. Demonstrating that these vaccines are safe and effective in monkeys is a promising indicator of their real potential for use in humans.
"When you see the tragedies these viruses cause, it's very frustrating that we can't do more to help people," said Dr. Feldmann, who (along with Dr. Jones and others from PHAC) has been providing on-site rapid diagnostic support to the current Marburg outbreak in Angola. "It'll be some time before we can use these vaccines in the field, but it's satisfying to know that we're getting closer."
According to Dr. Geisbert, this is the first vaccine system, or platform, that has protected nonhuman primates from both Ebola and Marburg. "In addition, the vaccine targets dendritic cells, which are the same cells that Ebola and Marburg attack," said Dr. Geisbert. "These cells are also important in generating a protective immune response. So the vaccine goes exactly where we want it to go."
The study describes how Canadian researchers developed the vaccines by replacing a surface protein in an animal pathogen, called vesicular stomatitis virus, with a surface protein from either the Ebola or Marburg viruses. Following extensive work, including trials with mice and guinea pigs, the PHAC researchers collaborated with USAMRIID to prove their efficacy in non-human primates.
Canadian Health Minister Ujjal Dosanjh and Dr. Carolyn Bennett, Minister of State (Public Health), praised the work of the scientists in developing the vaccine and providing support to the outbreak in Angola.
"This speaks volumes about the dedication and expertise of these individuals, and also what can be achieved through international collaboration," said Minister Dosanjh. Minister Bennett added that people everywhere could benefit from the vaccine development,"in stopping outbreaks where they originate as well as reducing the risk that these viruses will be used in bioterrorism."
Colonel Erik A. Henchal, commander of USAMRIID, said the study illustrates the benefits of collaborative research to develop medical countermeasures for biodefense.
"Relationships like this contribute to better science and ultimately better protection for military service members and civilians alike."
US Army Medical Research Institute of Infectious D
Viruses Current Events and Viruses News RSSNovel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants
Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system.
Study sheds light on causes of HIV dementia
A new study led by researchers at Albert Einstein College of Medicine of Yeshiva University has clarified how two major variants of HIV differ in their ability to cause neurologic complications.
Vaccine and drug research aimed at ticks and mosquitoes to prevent disease transmission
Most successful vaccines and drugs rely on protecting humans or animals by blocking certain bacteria from growing in their systems. But, a new theory actually hopes to take stopping infectious diseases such as West Nile virus and Malaria to the next level by disabling insects from transmitting these viruses.
CSHL scientists discover a new way in which epigenetic information is inherited
Hereditary information flows from parents to offspring not just through DNA but also through the millions of proteins and other molecules that cling to it.
Researchers recreate SARS virus, open door for potential defenses against future strains
Researchers at the University of North Carolina at Chapel Hill and Vanderbilt University Medical Center have synthetically reconstructed the bat variant of the SARS coronavirus (CoV) that caused the SARS epidemic of 2003.
Synthetic virus supports a bat origin for SARS
SARS - severe acute respiratory syndrome - alarmed the world five years ago as the first global pandemic of the 21st century. The coronavirus (SARS-CoV) that sickened more than 8,000 people - and killed nearly 800 of them - may have originated in bats, but the actual animal source is not known.
Researchers discover strategy for predicting the immunity of vaccines
In the first study of its kind, researchers at the Yerkes National Primate Research Center and Emory Vaccine Center, Emory University, have developed a multidisciplinary approach involving immunology, genomics and bioinformatics to predict the immunity of a vaccine without exposing individuals to infection.
Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models.
UT Southwestern researchers develop new strategy for broad spectrum anti-viral drugs
Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents.
Fall babies: Born to wheeze?
It is said that timing is everything, and that certainly appears to be true for autumn infants. Children who are born four months before the height of cold and flu season have a greater risk of developing childhood asthma than children born at any other time of year, according to new research.
More Viruses Current Events and Viruses News Articles
 | Emerging Viruses: AIDS And Ebola : Nature, Accident or Intentional? by Leonard G. Horowitz |
 | Understanding Viruses by Teri Shors Understanding Viruses is the ideal text for the modern undergraduate virology course. With a full-color design and rich pedagogy, the text provides a strong introduction to viruses in our daily lives and viral diseases from an epidemiological and global perspective. Its unique approach combines historical perspectives along with the clinical and molecular aspects of viral infections, and chapters... |
 | How Pathogenic Viruses Work by Lauren Sompayrac A clever, accessible overview that uses a survey of 12 of the most common viral infections, to teach the fundamental principles of human... |
 | Dengue Fever and Other Hemorrhagic Viruses (Deadly Diseases and Epidemics) by Tritha, Ph.D. Chakraborty Dengue fever is an infectious disease found around the world that is caused by four closely related, but distinct, types of viruses commonly transmitted by Aedes aegypti mosquitoes. Triggering excessive bleeding, dengue fever, dengue hemorrhagic fever, and dengue hemorrhagic shock can be fatal. "Dengue Fever and Other Hemorrhagic Viruses" explores the biology of the dengue virus and similar... |
 | Viruses and Human Disease, Second Edition by James H. Strauss, Ellen G. Strauss Completely revised and updated, the new edition of this groundbreaking text integrates basic virology with pathophysiological conditions to examine the connection between virology and human disease. Most virology textbooks focus on the molecular biology involved without adequate reference to physiology. This text focuses on viruses that infect humans, domestic animals and vertebrates and is based... |
 | Food-Borne Viruses: Progress and Challenges (Emerging Issues in Food Safety) This book addresses the gaps in our knowledge of foodborne viruses, and the implication of these gaps. It explains what lessons we can learn from the past about early detection and control of (emerging) viral infections. It looks at the role of viral changes through mutation and recombination on their biological properties and epidemiology. It features chapters written by leading scientists in... |
 | My Life with Viruses, Friends & Enemies by Alfred Prince |
 | Emerging Viruses New epidemics such as AIDS and "mad cow" disease have dramatized the need to explore the factors underlying rapid viral evolution and emerging viruses. This comprehensive volume is the first to describe this multifaceted new field. It places viral evolution and emergence in a historical context, describes the interaction of viruses with hosts, and details the advances in molecular biology and... |
 | Computer Viruses For Dummies by Peter H. Gregory Computer viruses—just the thought of your trusty PC catching one is probably enough to make you sick. Thanks to the cyber-sickies who persist in coming up with new strains, there’s a major new cyberattack nearly every day. Viruses sneak in, usually through e-mail. Fortunately, there are ways to inoculate and protect your computer. Computer Viruses For Dummies helps you: ... |
 | The Five-Second Rule and Other Myths About Germs: What Everyone Should Know About Bacteria, Viruses, Mold, and Mildew by Anne E. Maczulak |
| © 2008 BrightSurf.com |